<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: We have previously reported that the decrease in <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>)-cholesterol that is observed in patients with untreated <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> is limited to those with active disease </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To determine the effect of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, used in the treatment of active <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, on the reported <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> <z:hpo ids='HP_0001939'>metabolism abnormalities</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We studied 62 patients with biopsy-proven <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, <z:hpo ids='HP_0000001'>all</z:hpo> of them with active disease </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">Sarcoidosis</z:e> activity was evaluated by means of clinical, chest X-ray, <z:chebi fb="29" ids="49631">gallium</z:chebi>-67 scan, serum angiotensin-converting enzyme (peptidyl-dipeptidase A) values, and pulmonary function tests </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 40 patients were not treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi> and 22 patients were treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The mean daily <z:chebi fb="0" ids="8382">prednisone</z:chebi> dosage in the treated patients with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> was 20 mg and the mean duration of <z:chebi fb="0" ids="8382">prednisone</z:chebi> therapy was 6 months </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> metabolism included: serum cholesterol, <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>)-cholesterol, <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi>, <z:chebi fb="17" ids="39025">HDL</z:chebi>(2)-cholesterol, <z:chebi fb="17" ids="39025">HDL</z:chebi>(3)-cholesterol, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) A-I, apo B, and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> concentrations </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: When patients with active <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> not treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi> were compared to those treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi>, the former had significantly lower <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> (1.17+/-0.36 vs. 1.42+/-0.42 mmol/l; P=0.01) and <z:chebi fb="17" ids="39025">HDL</z:chebi>(2)-cholesterol (0.37+/-0.18 vs. 0.53+/-0.25 mmol/l; P=0.009) levels </plain></SENT>
<SENT sid="8" pm="."><plain>Multiple regression analysis demonstrated that the <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> (P=0.004), <z:chebi fb="17" ids="39025">HDL</z:chebi>(2)-cholesterol (P=0.002), <z:chebi fb="17" ids="39025">HDL</z:chebi>(3)-cholesterol (P=0.02), and apo A-I (P=0.02) levels were the variables independently and significantly associated with steroid therapy </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="50858">Corticosteroid</z:chebi> therapy, used in the treatment of active <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, <z:mp ids='MP_0001556'>increased HDL-cholesterol levels</z:mp> to those seen in inactive disease </plain></SENT>
<SENT sid="10" pm="."><plain>These changes are manifestations of reducing disease activity </plain></SENT>
</text></document>